This is a double-blind, randomized, study in three parallel groups which will test the effect of cilostazol on cardiovascular metabolism in patients with intermittent claudication. This is an investigator- initiated spin-off of a phase 3, multicentered trial to test the benefit-risk relationship of cilostazol in patients with peripheral vascular disease. Changes in cardiovascular metabolism will be determined by an analysis of variance. New protocol. BIOSTATISTICIAN ONLY.
Showing the most recent 10 out of 674 publications